5 Top Penny Stocks May 16, 2008
$7 online stock trades. You know you love 'em. (MSNBC -- Business)
Movers: Companies in the news Dec 17, 2007
The board of Harvard Bioscience has unanimously rejected an unsolicited offer from the company's largest shareholder, Skystone Advisors, which offered to buy the company, a maker of drug-discovery tools, for $5 a share ... " Skystone reported in a regulatory filing Friday that it had a 15.4 percent stake in Harvard Bioscience, making it the biggest shareholder. Skystone said Harvard Bioscience needed to double revenue and profit through a capital infusion and more aggressive acquisitions, rather... (International Herald Tribune -- Business Asia)
Harvard Bioscience rejects Skystone's $5-a-share acquisition offer Dec 15, 2007
SAN FRANCISCO (Thomson Financial) - Harvard Bioscience Inc. said late Friday its board has unanimously rejected an unsolicited, $5-a-share acquisition offer from Skystone Advisors LLC.. Harvard Bioscience (nasdaq: - - ) said the offer unvervalues the company ... We believe our current strategy of combining tuckunder acquisitions with organic growth can deliver better value to all our stockholders than the Skystone offer,' said Harvard Bioscience Chief Executive Chane Graziano in a letter to... (Forbes -- Markets)
Harvard Bioscience Holds Out Dec 15, 2007
Harvard Bioscience wants a better deal. The scientific instruments maker rejected Skystone Advisors' offer to take the company private for $5 a share in cash, saying the offer undervalues the company and is not in the best interest of the shareholders because Harvard Bioscience (nasdaq: - - ) s strategy of organic growth and acquisitions can deliver greater value than a Skystone buyout ... She points out that historically Harvard Biosciences acquisitions have been inconsistent because of the... (Forbes -- Markets)
